AMITRIPTYLINE AT LOW-DOSE AND TITRATED FOR IRRITABLE BOWEL SYNDROME AS SECOND-LINE TREATMENT (ATLANTIS): A RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL IN PRIMARY CARE
Alexander Charles Ford 1
Alex Wright-Hughes 1
Sarah L. Alderson 1
Pei Loo Ow 1
Matthew J. Ridd 2
Robbie Foy 2
Felicity L. Bishop 3
Matthew Chaddock 4
Heather Cook 5
Deborah Cooper 5
Catherine Fernandez 5
Elspeth A. Guthrie 5
Suzanne Hartley 5
Amy Herbert 5
Daniel Howdon 5
Roberta Longo 5
Delia P. Muir 5
Taposhi Nath 6
Sonia Newman 6
Christopher M. Taylor 6
Emma J. Teasdale 6
Ruth Thornton 6
Amanda J. Farrin 6
Hazel A. Everitt 6
1 University of Leeds, Leeds, United Kingdom
2 University of Bristol, Bristol, United Kingdom
3 University of Southampton, Southampton, United Kingdom
4 LetscureIBS, Leeds, United Kingdom
5 University of Exeter, Exeter, United Kingdom
6 Labcorp, Leeds, United Kingdom
Topic
IBD, Neurogastroenterology & Motility, Paediatrics, Small Intestine & Nutrition, Colorectal
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]